Incidence of endophthalmitis after intravitreal bevacizumab using aliquots prepared On-site in 2 operating rooms in Kuwait
Author(s) -
Vivek B. Wani,
Jamal Al-Kandari,
Khalid Al Sabti,
Faisal Aljassar,
Hussain Qali,
Niranjan Kumar,
Anilkumar Uboweja,
Khalid Al-Sabah,
Fahad Al Diab,
Saleh Al-Rashidi
Publication year - 2015
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.171784
Subject(s) - endophthalmitis , medicine , bevacizumab , incidence (geometry) , evisceration (ophthalmology) , ophthalmology , enucleation , surgery , vitrectomy , visual acuity , chemotherapy , physics , alternative medicine , pathology , optics
To report the incidence of endophthalmitis after intravitreal injection of bevacizumab and the outcomes of treatment of endophthalmitis at two centers in Kuwait.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom